Treatment White blood cell and differential white blood cell count
WBC (x103/µL) Neutrophils (x103/µL) Lymphocytes (x103/µL) Eosinophils (x103/µL) Monocytes (x103/µL) Basophils (x103/µL)
Control Oral 14.34 ± 3.48 4.46 ± 1.26 7.27 ± 1.68 1.35 ± 0.41 1.15 ± 0.21 0.09 ± 0.08
Acacia niloticaOral 13.53 ± 5.98 3.70 ± 1.68 7.45 ± 3.22 1.27 ± 0.55 1.06 ± 0.55 0.04 ± 0.09
Control IP 6.87 ± 0.71 2.18 ± 0.25 3.51 ± 0.33 0.59 ± 0.14 0.54 ± 0.13 0.04 ± 0.04
Acacia niloticaIP 6.74 ± 2.19 1.82 ± 0.65 3.74 ± 1.22 0.61 ± 0.21 0.53 ± 0.14 0.03 ± 0.05
Results are expressed as Mean ± Standard Deviation (SD) for five animals in each treatment; *p<0.05 is considered significant when the mean of the control animals issignificantly different from that of the extract treated animals by T-Test.
Table 5: The effects of oral and intraperitoneal administration of 1g/kg body weight of aqueous stem bark extracts of Acacia nilotica in mice for one month on differentialwhite blood cell count (WBC).